Overexpression of serine threonine tyrosine kinase 1/novel oncogene with kinase domain mRNA in patients with acute leukemia

Experimental Hematology

Volumn 37, Issue 7, 2009, Pages 824-830

  Kondoh, Takashi ^a   Kobayashi, Daisuke ^a   Tsuji, Naoki ^a   Kuribayashi, Kageaki ^a   Watanabe, Naoki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; IDARUBICIN; MESSENGER RNA; METHOTREXATE; PREDNISOLONE; PROTEIN TYROSINE KINASE; RETINOIC ACID; SERINE THREONINE TYROSINE KINASE 1; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; BLOOD CELL; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL STRAIN K 562; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TARGETING; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TETRASOMY; TRISOMY 21;

ACUTE DISEASE; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; FEMALE; HUMANS; INFANT; LEUKEMIA; MALE; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 67049173046     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2009.04.010     Document Type: Article

References (17)

1. Gilliland D.G. Molecular genetics of human leukemias: new insights into therapy. Semin Hematol 39 (2002) 6-11
2. Nakao M., Yokota S., Iwai T., et al. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 10 (1996) 1911-1918
3. Gambacorti-Passerini C.B., Gunby R.H., Piazza R., Galietta A., Rostagno R., and Scapozza L. Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias. Lancet Oncol 4 (2003) 75-85
4. Paietta E., Ferrando A.A., Neuberg D., et al. Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias. Blood 104 (2004) 558-560
5. Yanada M., Takeuchi J., Sugiura I., et al. High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group. J Clin Oncol 24 (2006) 460-466
6. Wang Y.Y., Zhou G.B., Yin T., et al. AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec. Proc Natl Acad Sci U S A 102 (2005) 1104-1109
7. George P., Bali P., Cohen P., et al. Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3. Cancer Res 64 (2004) 3645-3652
8. Liu L., Yu X.Z., Li T.S., et al. A novel protein tyrosine kinase NOK that shares homology with platelet-derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice. Cancer Res 64 (2004) 3491-3499
9. Ezzat S., Zheng L., Zhu X.F., Wu G.E., and Asa S.L. Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. J Clin Invest 109 (2002) 69-78
10. Wallenius V., Hisaoka M., Helou K., et al. Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors. Am J Pathol 156 (2002) 821-829
11. Moriai R., Kobayashi D., Amachika T., Tsuji N., and Watanabe N. Diagnostic relevance of overexpressed NOK mRNA in breast cancer. Anticancer Res 26 (2006) 4969-4973
12. Amachika T., Kobayashi D., Moriai R., Tsuji N., and Watanabe N. Diagnostic relevance of overexpressed mRNA of novel oncogene with kinase-domain (NOK) in lung cancers. Lung Cancer 56 (2007) 337-340
13. Kobayashi D., Watanabe N., Yamauchi N., Tsuji N., Sato T., and Niitsu Y. Endogenous tumor necrosis factor as a predictor of doxorubicin sensitivity in leukemic patients. Blood 89 (1997) 2472-2479
14. Harbott J., Viehmann S., Borkhardt A., Henze G., and Lampert F. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood 90 (1997) 4933-4937
15. Chen Y., Li Y.H., Chen X.P., et al. Point mutation at single tyrosine residue of novel oncogene NOK abrogates tumorigenesis in nude mice. Cancer Res 65 (2005) 10838-10846
16. Tazzari P.L., Cappellini A., Ricci F., et al. Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. Leukemia 21 (2007) 427-438
17. Chiarini F., Del Sole M., Mongiorgi S., et al. The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. Leukemia 22 (2008) 1106-1116